Beta Bionics, Inc. (BBNX) Total Current Liabilities (2023 - 2026)

Beta Bionics (BBNX) has 4 years of Total Current Liabilities data on file, last reported at $23.2 million in Q1 2026.

• Quarterly Total Current Liabilities rose 40.62% year-over-year to $23.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.2 million (up 40.62% YoY) and the FY2025 annual result came in at $30.9 million, up 46.23% from the prior year.
• Total Current Liabilities eased to $23.2 million in Q1 2026 per BBNX's latest filing, from $30.9 million in the prior quarter.
• The five-year high for Total Current Liabilities was $30.9 million in Q4 2025, with the low at $10.6 million in Q4 2023.
• Average Total Current Liabilities over 4 years is $21.0 million, with a median of $21.1 million recorded in 2024.
• Year-over-year, Total Current Liabilities jumped 99.42% in 2024 and jumped 40.62% in 2026.
• Beta Bionics' Total Current Liabilities stood at $10.6 million in 2023, then jumped by 99.42% to $21.1 million in 2024, then soared by 46.23% to $30.9 million in 2025, then fell by 25.01% to $23.2 million in 2026.
• Business Quant data shows BBNX's Total Current Liabilities at $23.2 million in Q1 2026, $30.9 million in Q4 2025, and $25.4 million in Q3 2025.